Borges WG, Augustine NH, Hill HR (fevereiro de 2000). «Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome». The Journal of Pediatrics. 136 (2): 176–80. PMID10657822. doi:10.1016/S0022-3476(00)70098-9
Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. (outubro de 2007). «STAT3 mutations in the hyper-IgE syndrome». The New England Journal of Medicine. 357 (16): 1608–19. PMID17881745. doi:10.1056/NEJMoa073687
Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, et al. (20 de maio de 2014). «Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern». Allergy. 69 (7): 943–953. PMID24840882. doi:10.1111/all.12416
Yang L, Fliegauf M, Grimbacher B (dezembro de 2014). «Hyper-IgE syndromes: reviewing PGM3 deficiency». Current Opinion in Pediatrics. 26 (6): 697–703. PMID25365149. doi:10.1097/MOP.0000000000000158
Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. (novembro de 2006). «Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity». Immunity. 25 (5): 745–55. PMID17088085. doi:10.1016/j.immuni.2006.09.009
Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. (março de 1999). «Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder». The New England Journal of Medicine. 340 (9): 692–702. PMID10053178. doi:10.1056/NEJM199903043400904
Kimata H (março de 1995). «High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome». The Journal of Allergy and Clinical Immunology. 95 (3): 771–4. PMID7897163. doi:10.1016/S0091-6749(95)70185-0
Borges WG, Augustine NH, Hill HR (fevereiro de 2000). «Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome». The Journal of Pediatrics. 136 (2): 176–80. PMID10657822. doi:10.1016/S0022-3476(00)70098-9
Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. (outubro de 2007). «STAT3 mutations in the hyper-IgE syndrome». The New England Journal of Medicine. 357 (16): 1608–19. PMID17881745. doi:10.1056/NEJMoa073687
Hafsi, Wissem; Yarrarapu, Siva Naga S. (2021), «Job Syndrome», Treasure Island (FL): StatPearls Publishing, StatPearls, PMID30247822, consultado em 28 de novembro de 2021
Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, et al. (20 de maio de 2014). «Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern». Allergy. 69 (7): 943–953. PMID24840882. doi:10.1111/all.12416
Yang L, Fliegauf M, Grimbacher B (dezembro de 2014). «Hyper-IgE syndromes: reviewing PGM3 deficiency». Current Opinion in Pediatrics. 26 (6): 697–703. PMID25365149. doi:10.1097/MOP.0000000000000158
Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. (março de 1999). «Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder». The New England Journal of Medicine. 340 (9): 692–702. PMID10053178. doi:10.1056/NEJM199903043400904
Kimata H (março de 1995). «High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome». The Journal of Allergy and Clinical Immunology. 95 (3): 771–4. PMID7897163. doi:10.1016/S0091-6749(95)70185-0
Buckley RH, Wray BB, Belmaker EZ (janeiro de 1972). «Extreme hyperimmunoglobulinemia E and undue susceptibility to infection». Pediatrics. 49 (1): 59–70. PMID5059313